Literature DB >> 11478489

Assessment of liver histology in chronic alcoholics with and without hepatitis C virus infection.

S Anderson1, C L Nevins, L K Green, H El-Zimaity, B S Anand.   

Abstract

Patients with alcoholic liver disease have a high prevalence of hepatitis C virus (HCV) infection. The histological appearances of the liver in patients with alcoholic liver disease and HCV infection are well described. However, liver histology in individuals with dual pathology, both chronic alcohol abuse and HCV infection, is less well understood. The purpose of the present study was to examine this issue and to determine if there is any correlation between specific histological features and the serum biochemical abnormalities seen in these patients. Eighty-six chronic alcoholics, 65 with HCV infection and 21 uninfected subjects, were included in the study. All patients had history of heavy alcohol abuse (consuming 80 g or more of ethanol a day for at least 10 years). The following data were collected on each patient: demographic information (age, gender, race), the amount and duration of alcohol intake, biochemical results, and liver biopsy abnormalities including the histological activity index (HAI) score. HCV-infected alcoholics were younger (P = 0.05) and were more often African American than Caucasian (P < 0.01). Alcohol consumption was significantly greater in uninfected alcoholics compared to those with HCV infection (P < 0.05). Liver histology in subjects with HCV infection showed higher HAI scores for intralobular necrosis (P = 0.008) and periportal inflammation (P = 0.004). Features of "chronic hepatitis" and focal lymphoid aggregates were more frequent in HCV-infected alcoholics (P = 0.001 for each). By contrast, cirrhosis was present in a higher proportion of uninfected alcoholics compared to those with HCV infection (P = 0.05). Histological findings of hepatic fibrosis and total HAI score showed a significant correlation with serum albumin and platelet count in HCV-infected alcoholics. Chronic alcoholics with HCV infection have specific histological appearances that can usually help distinguish these patients from uninfected alcoholics. Correlation analysis indicates that of the various laboratory tests, serum albumin and platelet counts are the best predictors of the severity of liver damage at histology. In chronic alcoholics, the development of cirrhosis is related more to the amount of alcohol consumed than to the presence of HCV infection.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11478489     DOI: 10.1023/a:1010671300507

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  30 in total

Review 1.  Influence of chronic alcohol abuse on hepatitis C virus replication.

Authors:  B S Anand; M Velez
Journal:  Dig Dis       Date:  2000       Impact factor: 2.404

2.  Hepatitis C viremia and anti-HCV antibodies in alcoholics.

Authors:  B Nalpas; V Thiers; S Pol; F Driss; V Thepot; P Berthelot; C Brechot
Journal:  J Hepatol       Date:  1992-03       Impact factor: 25.083

3.  The prevalence of hepatitis C virus infection in the United States, 1988 through 1994.

Authors:  M J Alter; D Kruszon-Moran; O V Nainan; G M McQuillan; F Gao; L A Moyer; R A Kaslow; H S Margolis
Journal:  N Engl J Med       Date:  1999-08-19       Impact factor: 91.245

4.  Relevance of anti-HCV reactivity in patients with alcoholic hepatitis. VA cooperative Study Group #275.

Authors:  C L Mendenhall; T Moritz; A Chedid; A J Polito; S Quan; S Rouster; G Roselle
Journal:  Gastroenterol Jpn       Date:  1993-05

5.  Detection of hepatitis C virus antibodies and hepatitis C virus RNA in patients with alcoholic liver disease.

Authors:  S Nishiguchi; T Kuroki; T Yabusako; S Seki; K Kobayashi; T Monna; S Otani; M Sakurai; T Shikata; S Yamamoto
Journal:  Hepatology       Date:  1991-12       Impact factor: 17.425

6.  Epidemiology of hepatitis C among veterans with alcoholic liver disease. The VA Cooperative Study Group 275.

Authors:  C L Mendenhall; T Moritz; S Rouster; G Roselle; A Polito; S Quan; R K DiNelle
Journal:  Am J Gastroenterol       Date:  1993-07       Impact factor: 10.864

7.  Hepatitis C virus in alcoholic patients with and without clinically apparent liver disease.

Authors:  M E Coelho-Little; L J Jeffers; D E Bernstein; J J Goodman; K R Reddy; M de Medina; X Li; M Hill; S La Rue; E R Schiff
Journal:  Alcohol Clin Exp Res       Date:  1995-10       Impact factor: 3.455

8.  Effects of alcohol on the replication of hepatitis C virus.

Authors:  M Sawada; A Takada; S Takase; N Takada
Journal:  Alcohol Alcohol Suppl       Date:  1993

9.  The characteristics of alcoholics with HCV infection: histopathologic comparison with alcoholics without HCV infection and chronic type C hepatitis.

Authors:  M Nakano; K Maruyama; K Okuyama; H Takahashi; K Yokoyama; S Takagi; H Shiraki; H Ishii
Journal:  Alcohol Alcohol Suppl       Date:  1993

10.  Detection of hepatitis C virus antibodies and hepatitis C virus RNA in patients with alcoholic liver disease.

Authors:  J C Bode; D M Alscher; H Wisser; C Bode
Journal:  Alcohol Alcohol       Date:  1995-01       Impact factor: 2.826

View more
  4 in total

1.  Molecular mechanisms involved in the interaction effects of alcohol and hepatitis C virus in liver cirrhosis.

Authors:  Valeria R Mas; Ryan Fassnacht; Kellie J Archer; Daniel Maluf
Journal:  Mol Med       Date:  2010-03-26       Impact factor: 6.354

2.  Referrals for surgical therapy in patients with hepatocellular carcinoma: a community experience.

Authors:  Thomas S Helling; Charles E Woodall
Journal:  J Gastrointest Surg       Date:  2007-01       Impact factor: 3.452

Review 3.  Hepatitis C virus: A critical approach to who really needs treatment.

Authors:  Elias Kouroumalis; Argyro Voumvouraki
Journal:  World J Hepatol       Date:  2022-01-27

4.  Predictive role of acute phase reactants in the response to therapy in patients with chronic hepatitis C virus infection.

Authors:  Ayten Oguz; Ahmet Engin Atay; Adnan Tas; Gulseren Seven; Mehmet Koruk
Journal:  Gut Liver       Date:  2012-11-13       Impact factor: 4.519

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.